BMP4 Is Dispensable for Skeletogenesis and Fracture-Healing in the Limb

Tsuji, Kunikazu; Cox, Karen; Bandyopadhyay, Amitabha; Harfe, Brian D.; Tabin, Clifford J.; Rosen, Vicki
February 2008
Journal of Bone & Joint Surgery, American Volume;Feb2008 Supplement 1, Vol. 90-A, p14
Academic Journal
Bone morphogenetic proteins (BMPs) are potent bone-forming agents that show clinical efficacy when used in patients to augment fracture-healing. Molecular profiling of fracture tissues has confirmed that BMPs 2, 3, 4, 5, 6, and 7 are expressed during the healing process, and it has identified a specific temporal pattern of expression for each BMP. Mice engineered to express increased levels of BMP antagonists have fragile bones that are prone to fracture, suggesting that BMPs not only mediate bone formation in the context of repair, but may also have a role in maintaining adult bone. In this study, mice carrying floxed Bmp4 alleles were bred with Prx1-cre transgenic mice to establish limb-specific removal of Bmp4. We compared these mice to mice in which Bmp2 was specifically deleted from the limb, and we then assessed limb skeletogenesis and fracture-healing. Limb skeletogenesis occurs normally in the absence of BMP4, and postnatal skeletal growth was also unaffected when BMP4 was removed. When mice lacking BMP4 were challenged to repair fractures, they were able to mount a successful healing response. We concluded that BMP4 is not required for formation of the limb skeleton and that femur fracture-healing is unaffected by the absence of BMP4. This study demonstrates that BMP4 is not required for bone formation and function in the limb, giving us further insights into the utility of recombinant human BMPs as therapeutic agents.


Related Articles

  • Functional Restoration of Critically Sized Segmental Defects With Bone Morphogenetic Protein-2 and Heparin Treatment. Johnson, Mela; Boerckel, Joel; Dupont, Kenneth; Guldberg, Robert // Clinical Orthopaedics & Related Research;Nov2011, Vol. 469 Issue 11, p3111 

    Background: Bone defects and fracture nonunions remain a substantial challenge for clinicians. Grafting procedures are limited by insufficient volume and donor site morbidity. As an alternative, biomaterial scaffolds functionalized through incorporation of growth factors such as bone...

  • Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: Current challenges in BMP delivery. Haidar, Ziyad S.; Hamdy, Reggie C.; Tabrizian, Maryam // Biotechnology Letters;Dec2009, Vol. 31 Issue 12, p1817 

    Recombinant human bone morphogenetic proteins (rhBMPs) have been extensively investigated for developing therapeutic strategies aimed at the restoration and treatment of orthopaedic as well as craniofacial conditions. In this first part of the review, we discuss the rationale for the necessary...

  • Effect of Escherichia coli-produced recombinant human bone morphogenetic protein 2 on the regeneration of canine segmental ulnar defects. Harada, Yasuji; Itoi, Takamasa; Wakitani, Shigeyuki; Irie, Hiroyuki; Sakamoto, Michiko; Zhao, Dongwei; Nezu, Yoshinori; Yogo, Takuya; Hara, Yasushi; Tagawa, Masahiro // Journal of Bone & Mineral Metabolism;Jul2012, Vol. 30 Issue 4, p388 

    Because bone morphogenetic protein 2 gene transfected Escherichia coli (E-BMP-2) produce recombinant human BMP-2 (rhBMP-2) more efficiently than mammalian cells (Chinese hamster ovary [CHO]-BMP-2), they may be a more cost-effective source of rhBMP-2 for clinical use. However, use of E-BMP-2 for...

  • BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Tsuji, Kunikazu; Bandyopadhyay, Amitabha; Harfe, Brian D.; Cox, Karen; Kakar, Sanjeev; Gerstenfeld, Louis; Einhorn, Thomas; Tabin, Clifford J.; Rosen, Vicki // Nature Genetics;Dec2006, Vol. 38 Issue 12, p1424 

    Adult bones have a notable regenerative capacity. Over 40 years ago, an intrinsic activity capable of initiating this reparative response was found to reside within bone itself, and the term bone morphogenetic protein (BMP) was coined to describe the molecules responsible for it. A family of BMP...

  • Ankaferd Blood Stopper: Does it have a role in fracture healing? GÜNAY, Murat; AMANVERMEZ, Ramazan; KELEŞ, Gökhan // Turkish Journal of Medical Sciences;Oct2013, Vol. 43 Issue 5, p733 

    Aim: To examine the effect of Ankaferd Blood Stopper (ABS) on bone healing using a rat femur fracture model. Materials and methods: Eight rats were used as a control group (group 1), which was not subjected to fractures. The remaining 48 rats were divided into 6 groups of 8 each. The femoral...

  • Use and efficacy of bone morphogenetic proteins in fracture healing. Lissenberg-Thunnissen, Suzanne; Gorter, David; Sier, Cornelis; Schipper, Inger // International Orthopaedics;Sep2011, Vol. 35 Issue 9, p1271 

    Purpose: This review evaluates the application of bone morphogenetic proteins (BMPs) in delayed bone repair, aiming at a broad audience from clinicians to scientists. Next to an overview of the role of the different BMPs, their antagonists and their current applications, special attention is...

  • Rat adipose-derived stromal cells expressing BMP4 induce ectopic bone formation in vitro and in vivo. Lin Lin; Xin Fu; Xin Zhang; Lian-xu Chen; Ji-ying Zhang; Chang-long Yu; Kang-tao Ma; Chun-yan Zhou // Acta Pharmacologica Sinica;Dec2006, Vol. 27 Issue 12, p1608 

    Aim: Bone morphogenetic protein 4 (BMP4) is one of the main local contributing factors in callus formation in the early phase of fracture healing. Adipose-derived stromal cells (ADSC) are multipotent cells. The present study was conducted to investigate the osteogenic potential of ADSC when...

  • RHBMP-2/CALCIUM PHOSPHATE MATRIX ACCELERATES OSTEOTOMY-SITE HEALING IN A NONHUMAN PRIMATE MODEL AT MULTIPLE TREATMENT TIMES AND CONCENTRATIONS. Seeherman, Howard; Rebecca Li; Bouxsein, Mary; Hyun Kim; Li, X. Jian; Smith-Adaline, Erica A.; Aiolova, Maria; Wozney, John M. // Journal of Bone & Joint Surgery, American Volume;Jan2006, Vol. 88-A Issue 1, p144 

    Background: While recombinant human bone morphogenetic protein-2 (rhBMP-2) administered in a calcium phosphate cement accelerates osteotomy-site healing in animal models when administered three hours after surgery, definitive fracture treatment is often delayed. The present study evaluated the...

  • A biodegradable polymer as a cytokine delivery system for inducing bone formation. Saito, Naoto; Okada, Takao; Horiuchi, Hiroshi; Murakami, Narumichi; Takahashi, Jun; Nawata, Masashi; Ota, Hiroshi; Nozaki, Kazutoshi; Takaoka, Kunio // Nature Biotechnology;Apr2001, Vol. 19 Issue 4, p332 

    Bone morphogenetic proteins (BMPs) that have the potential to elicit new bonein vivo have been used in a tissue-engineering approach for the repair of bone injuries and bone defects. Although it is now possible to generate large amounts of recombinant human (rh) BMPs for medical use, the major...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics